X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35) 35
multiple sclerosis (35) 35
humans (33) 33
clinical neurology (30) 30
female (24) 24
neurosciences (24) 24
adult (21) 21
male (18) 18
neurology (16) 16
middle aged (12) 12
multiple-sclerosis (12) 12
natalizumab (12) 12
immunology (11) 11
magnetic resonance imaging (9) 9
performing operations (9) 9
transporting (9) 9
experimental autoimmune encephalomyelitis (8) 8
medicine & public health (8) 8
patients (8) 8
vehicles in general (8) 8
young adult (8) 8
animals (7) 7
autoimmunity (7) 7
care and treatment (7) 7
killer cells (7) 7
multiple sclerosis - drug therapy (7) 7
neuroradiology (7) 7
nk cells (7) 7
research (7) 7
risk factors (7) 7
advertising (6) 6
allergy and immunology (6) 6
analysis (6) 6
arrangement of signalling or lighting devices, the mounting orsupporting thereof or circuits therefor, for vehicles ingeneral (6) 6
clinical trials (6) 6
cryptography (6) 6
disability (6) 6
display (6) 6
displaying (6) 6
drug therapy (6) 6
education (6) 6
fingolimod (6) 6
labels or name-plates (6) 6
multiple sclerosis, relapsing-remitting - drug therapy (6) 6
physics (6) 6
progressive multifocal leukoencephalopathy (6) 6
psychiatry (6) 6
seals (6) 6
signs (6) 6
therapy (6) 6
antibodies, monoclonal - therapeutic use (5) 5
cohort studies (5) 5
diagnosis (5) 5
disease progression (5) 5
immunosuppressive agents - therapeutic use (5) 5
marrow stromal cells (5) 5
mri (5) 5
multiple sclerosis - therapy (5) 5
retrospective studies (5) 5
stem cells (5) 5
treatment outcome (5) 5
adolescent (4) 4
alemtuzumab (4) 4
antibodies, monoclonal, humanized (4) 4
disability evaluation (4) 4
disease (4) 4
follow-up studies (4) 4
immunologic factors - adverse effects (4) 4
immunosuppressive agents - adverse effects (4) 4
inflammation (4) 4
interferon (4) 4
lymphocytes (4) 4
mesenchymal stem cells (4) 4
multiple sclerosis - immunology (4) 4
natural killer cells (4) 4
natural-killer-cells (4) 4
neurosurgery (4) 4
nuclear magnetic resonance--nmr (4) 4
ophthalmology (4) 4
pregnancy (4) 4
prognosis (4) 4
risk (4) 4
t cells (4) 4
vehicles, vehicle fittings, or vehicle parts, not otherwiseprovided for (4) 4
abridged index medicus (3) 3
aged (3) 3
amyotrophic-lateral-sclerosis (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
article (3) 3
brain - pathology (3) 3
cd56bright nk cells (3) 3
cerebrospinal-fluid (3) 3
chemistry (3) 3
clinically isolated syndrome (3) 3
double-blind (3) 3
drug therapy, combination (3) 3
drugs (3) 3
fingolimod hydrochloride (3) 3
functional recovery (3) 3
health aspects (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2003, Romanzi e racconti, ISBN 8831782509, 315
Book
Multiple Sclerosis Journal, ISSN 1352-4585, 4/2019, Volume 25, Issue 4, pp. 510 - 512
Journal Article
1980, 1. ed. --, Saggi, Volume n. 82, 160 p., [16] leaves of plates
Book
Lancet Neurology, The, ISSN 1474-4422, 2017, Volume 16, Issue 4, pp. 252 - 253
  Baseline MRI activity is a major determinant of treatment choice, which should be adjusted for. [...]MRI activity might drive treatment switch, introducing... 
Neurology | DISABILITY | ALEMTUZUMAB | CLINICAL NEUROLOGY | Drug therapy | Drug approval | Multiple sclerosis | Drugs | Studies | Pragmatism | Quality | Clinical trials | Interferon
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 7/2018, Volume 24, Issue 8, pp. 1133 - 1137
We present the neuropathological description of an autoptic case of fatal rebound of disease activity after fingolimod discontinuation in a multiple sclerosis... 
histopathology | post mortem | Fingolimod | glia | demyelination | multiple sclerosis | WITHDRAWAL | NEUROSCIENCES | CLINICAL NEUROLOGY | CESSATION | Multiple sclerosis | Gliosis | Magnetic resonance imaging | Neuropathology | Astrocytes | Demyelination | Substantia alba | Sphingosine 1-phosphate
Journal Article
Journal Article